Related Tags >> GlaxoSmithKline Biogen Idec Merck Kgaa Generics

Wockhardt News

Most Popular Wockhardt Story

Rumor Mill: Indian drug makers court Par

September 18, 2007 — 6:59am ET

At least three Indian drug makers were spotted with chocolate and flowers at the headquarters of Par Pharmaceuticals, one of the top 10 generics companies in the U.S. Several Indian newspapers are... Read more...

Wockhardt Press Releases

Wockhardt takes huge strides towards In-licensing and collaborative agreements

Latest Headlines

ALSO NOTED: Wockhardt gets OK for Zithromax copy; Depomed's gabapentin formula passes Phase II;
February 12, 2008
ALSO NOTED: Forest sues generics over Namenda; Omrix gets new indication for Evicel;
January 11, 2008
ALSO NOTED: Barr challenges Sanofi patents on $1.1B drug; Wockhardt to launch copycat Zoloft;
January 9, 2008
ALSO NOTED: Sepracor chair to retire in May; Study shows Glaxo drug outpacing Pfizer's Spiriva;
January 2, 2008
ALSO NOTED: GSK suing Abbott over HIV-drug price; Harvard genius joins MIT-Novartis effort;
November 12, 2007
ALSO NOTED: Strong euro hitting Merck KGaA's revenue; U.S. sales boost Lupin's Q3 profits;
October 24, 2007
ALSO NOTED: Layoffs depress J&J profits; Canada OKs Pfizer HIV med;
October 16, 2007
Rumor Mill: Indian drug makers court Par
September 18, 2007
SPOTLIGHT: Orion battles generic
September 14, 2007

Paid Research Reports